{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:57:02Z","timestamp":1790870222804,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20147-9","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:31:02Z","timestamp":1784053862000},"page":"9834-9843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improved Oncologic Outcomes with Trimodality Therapy for Radiation-Associated Angiosarcoma of the Breast"],"prefix":"10.1245","volume":"33","author":[{"given":"Saskia J.","family":"Leonard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina J.","family":"Hieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Jakub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Sae-Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"25","key":"20147_CR1","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.18632\/oncotarget.26809","volume":"10","author":"MM Gage","year":"2019","unstructured":"Gage MM, Nagarajan N, Ruck JM, et al. Sarcomas in the United States: recent trends and a call for improved staging. Oncotarget. 2019;10(25):2462\u201374. https:\/\/doi.org\/10.18632\/oncotarget.26809.","journal-title":"Oncotarget."},{"issue":"11","key":"20147_CR2","first-page":"2303","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Wang J, He C, Fang M. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019;9(11):2303\u201313.","journal-title":"Am J Cancer Res."},{"issue":"4","key":"20147_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1245\/s10434-012-2755-y","volume":"20","author":"KE Torres","year":"2013","unstructured":"Torres KE, Ravi V, Kin K, et al. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013;20(4):1267\u201374. https:\/\/doi.org\/10.1245\/s10434-012-2755-y.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"20147_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamaoncol.2018.6643","volume":"5","author":"AJM Rombouts","year":"2019","unstructured":"Rombouts AJM, Huising J, Hugen N, et al. Assessment of radiotherapy-associated angiosarcoma after breast cancer treatment in a Dutch population-based study. JAMA Oncol. 2019;5(2):267\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2018.6643.","journal-title":"JAMA Oncol."},{"issue":"8","key":"20147_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/jpm14080859","volume":"14","author":"S Cozzi","year":"2024","unstructured":"Cozzi S, Finocchi Ghersi S, Tava F, et al. Radiation-associated angiosarcoma of the breast: the state of the art of a rare and aggressive disease. J Pers Med. 2024;14(8):859. https:\/\/doi.org\/10.3390\/jpm14080859.","journal-title":"J Pers Med."},{"issue":"5","key":"20147_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0360-3016(01)02799-7","volume":"52","author":"J Yap","year":"2002","unstructured":"Yap J, Chuba PJ, Thomas R, et al. Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(5):1231\u20137. https:\/\/doi.org\/10.1016\/s0360-3016(01)02799-7.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"12","key":"20147_CR7","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1245\/s10434-012-2563-4","volume":"19","author":"EA Morgan","year":"2012","unstructured":"Morgan EA, Kozono DE, Wang Q, et al. Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Ann Surg Oncol. 2012;19(12):3801\u20138. https:\/\/doi.org\/10.1245\/s10434-012-2563-4.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"20147_CR8","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/bjc.2013.590","volume":"109","author":"SP D'Angelo","year":"2013","unstructured":"D\u2019Angelo SP, Antonescu CR, Kuk D, et al. High-risk features in radiation-associated breast angiosarcomas. Br J Cancer. 2013;109(9):2340\u20136. https:\/\/doi.org\/10.1038\/bjc.2013.590.","journal-title":"Br J Cancer."},{"issue":"8","key":"20147_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/jso.24780","volume":"116","author":"MK Gervais","year":"2017","unstructured":"Gervais MK, Burtenshaw SM, Maxwell J, et al. Clinical outcomes in breast angiosarcoma patients: a rare tumor with unique challenges. J Surg Oncol. 2017;116(8):1056\u201361. https:\/\/doi.org\/10.1002\/jso.24780.","journal-title":"J Surg Oncol."},{"issue":"4","key":"20147_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/bjs.10696","volume":"105","author":"L Feinberg","year":"2018","unstructured":"Feinberg L, Srinivasan A, Singh JK, et al. Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. Br J Surg. 2018;105(4):401\u20139. https:\/\/doi.org\/10.1002\/bjs.10696.","journal-title":"Br J Surg."},{"issue":"7","key":"20147_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3109\/0284186X.2014.983657","volume":"54","author":"E Styring","year":"2015","unstructured":"Styring E, Klasson S, Rydholm A, Vult von Steyern F. Radiation-associated angiosarcoma after breast cancer: improved survival by excision of all irradiated skin and soft tissue of the thoracic wall? A report of six patients. Acta Oncol. 2015;54(7):1078\u201380. https:\/\/doi.org\/10.3109\/0284186X.2014.983657.","journal-title":"Acta Oncol."},{"issue":"4","key":"20147_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/SLA.0000000000001753","volume":"265","author":"GZ Li","year":"2017","unstructured":"Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP. Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival. Ann Surg. 2017;265(4):814\u201320. https:\/\/doi.org\/10.1097\/SLA.0000000000001753.","journal-title":"Ann Surg."},{"issue":"4","key":"20147_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1245\/s10434-019-08085-1","volume":"27","author":"SH Salminen","year":"2020","unstructured":"Salminen SH, Wiklund T, Sampo MM, et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol. 2020;27(4):1002\u201310. https:\/\/doi.org\/10.1245\/s10434-019-08085-1.","journal-title":"Ann Surg Oncol."},{"issue":"16","key":"20147_CR14","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.ejca.2008.07.037","volume":"44","author":"M Schlemmer","year":"2008","unstructured":"Schlemmer M, Reichardt P, Verweij J, et al. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer. 2008;44(16):2433\u20136. https:\/\/doi.org\/10.1016\/j.ejca.2008.07.037.","journal-title":"Eur J Cancer."},{"issue":"2","key":"20147_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/COC.0b013e3182436ea3","volume":"36","author":"MT Scott","year":"2013","unstructured":"Scott MT, Portnow LH, Morris CG, et al. Radiation therapy for angiosarcoma: the 35\u00a0year University of Florida experience. Am J Clin Oncol. 2013;36(2):174\u201380. https:\/\/doi.org\/10.1097\/COC.0b013e3182436ea3.","journal-title":"Am J Clin Oncol."},{"issue":"5","key":"20147_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COC.0000000000000077","volume":"39","author":"ER Ghareeb","year":"2016","unstructured":"Ghareeb ER, Bhargava R, Vargo JA, Florea AV, Beriwal S. Primary and radiation-induced breast angiosarcoma: clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy. Am J Clin Oncol. 2016;39(5):463\u20137. https:\/\/doi.org\/10.1097\/COC.0000000000000077.","journal-title":"Am J Clin Oncol."},{"issue":"10","key":"20147_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ejca.2014.03.002","volume":"50","author":"AL Depla","year":"2014","unstructured":"Depla AL, Scharloo-Karels CH, de Jong MAA, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779\u201388. https:\/\/doi.org\/10.1016\/j.ejca.2014.03.002.","journal-title":"Eur J Cancer."},{"issue":"2","key":"20147_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/0284186X.2013.819117","volume":"53","author":"TL Smith","year":"2014","unstructured":"Smith TL, Morris CG, Mendenhall NP. Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol. 2014;53(2):235\u201341. https:\/\/doi.org\/10.3109\/0284186X.2013.819117.","journal-title":"Acta Oncol."},{"issue":"15","key":"20147_CR19","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-23-0443","volume":"29","author":"AC Degnim","year":"2023","unstructured":"Degnim AC, Siontis BL, Ahmed SK, et al. Trimodality therapy improves disease control in radiation-associated angiosarcoma of the breast. Clin Cancer Res. 2023;29(15):2885\u201393. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0443.","journal-title":"Clin Cancer Res."},{"issue":"2","key":"20147_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amjsurg.2010.12.011","volume":"203","author":"N Jallali","year":"2012","unstructured":"Jallali N, James S, Searle A, Ghattaura A, Hayes A, Harris P. Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg. 2012;203(2):156\u201361. https:\/\/doi.org\/10.1016\/j.amjsurg.2010.12.011.","journal-title":"Am J Surg."},{"issue":"9325","key":"20147_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O'Sullivan","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235\u201341. https:\/\/doi.org\/10.1016\/S0140-6736(02)09292-9.","journal-title":"Lancet."},{"issue":"1","key":"20147_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12885-018-4369-7","volume":"18","author":"A Dogan","year":"2018","unstructured":"Dogan A, Kern P, Schultheis B, Hausler G, Rezniczek GA, Tempfer CB. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature. BMC Cancer. 2018;18(1):463. https:\/\/doi.org\/10.1186\/s12885-018-4369-7.","journal-title":"BMC Cancer."},{"issue":"12","key":"20147_CR23","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/ans.19231","volume":"94","author":"E Mor","year":"2024","unstructured":"Mor E, Baker B, Henderson MA, et al. Outcomes following extended resection of radiation-induced angiosarcoma of the breast: a sarcoma unit experience and systematic review. ANZ J Surg. 2024;94(12):2150\u20138. https:\/\/doi.org\/10.1111\/ans.19231.","journal-title":"ANZ J Surg."},{"issue":"6","key":"20147_CR24","doi-asserted-by":"publisher","first-page":"103474","DOI":"10.1016\/j.esmoop.2024.103474","volume":"9","author":"E Palassini","year":"2024","unstructured":"Palassini E, Baldi GG, Ciniselli CM, et al. Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis. ESMO Open. 2024;9(6):103474. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103474.","journal-title":"ESMO Open."},{"issue":"4","key":"20147_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.ijrobp.2023.12.050","volume":"119","author":"W Asha","year":"2024","unstructured":"Asha W, Al-Hilli Z, Djohan R, et al. Neoadjuvant reirradiation for radiation therapy-associated angiosarcoma of the breast. Int J Radiat Oncol Biol Phys. 2024;119(4):1082\u20135. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.12.050.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"20147_CR26","doi-asserted-by":"publisher","first-page":"103825","DOI":"10.1016\/j.breast.2024.103825","volume":"78","author":"SJC van der Burg","year":"2024","unstructured":"van der Burg SJC, Reijers SJM, Kuijpers A, et al. Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study. Breast. 2024;78:103825. https:\/\/doi.org\/10.1016\/j.breast.2024.103825.","journal-title":"Breast."},{"issue":"9","key":"20147_CR27","doi-asserted-by":"publisher","first-page":"110202","DOI":"10.1016\/j.ejso.2025.110202","volume":"51","author":"A Michot","year":"2025","unstructured":"Michot A, Giraud A, Karanian M, et al. Radiation-associated angiosarcoma of the breast: consider chemotherapy. Eur J Surg Oncol. 2025;51(9):110202. https:\/\/doi.org\/10.1016\/j.ejso.2025.110202.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"20147_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2017.03.016","volume":"98","author":"DW Arthur","year":"2017","unstructured":"Arthur DW, Winter KA, Kuerer HM, et al. NRG oncology-radiation therapy Oncology group study 1014: 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence. Int J Radiat Oncol Biol Phys. 2017;98(5):1028\u201335. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.016.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"20147_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-025-07779-3","volume":"213","author":"SSW Tse","year":"2025","unstructured":"Tse SSW, Hircock C, Karam I, et al. Repeat lumpectomy and external beam radiation therapy for ipsilateral breast cancer recurrence: a systematic review. Breast Cancer Res Treat. 2025;213(2):205\u201317. https:\/\/doi.org\/10.1007\/s10549-025-07779-3.","journal-title":"Breast Cancer Res Treat."},{"issue":"1132","key":"20147_CR30","doi-asserted-by":"publisher","first-page":"20201292","DOI":"10.1259\/bjr.20201292","volume":"95","author":"D Gabrys","year":"2022","unstructured":"Gabrys D, Kulik R, Namysl-Kaletka A. Re-irradiation for intra-thoracic tumours and extra-thoracic breast cancer: dose accumulation, evaluation of efficacy and toxicity based on a literature review. Br J Radiol. 2022;95(1132):20201292. https:\/\/doi.org\/10.1259\/bjr.20201292.","journal-title":"Br J Radiol."},{"issue":"1","key":"20147_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.21873\/anticanres.15461","volume":"42","author":"M Sayan","year":"2022","unstructured":"Sayan M, Vergalasova I, Jan I, et al. Toxicities and locoregional control after external beam chest wall and\/or regional lymph node re-irradiation for recurrent breast cancer. Anticancer Res. 2022;42(1):93\u20136. https:\/\/doi.org\/10.21873\/anticanres.15461.","journal-title":"Anticancer Res."},{"issue":"2","key":"20147_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10549-021-06206-7","volume":"188","author":"I Chen","year":"2021","unstructured":"Chen I, Botty Van den Bruele AM, Gillespie EF, et al. Salvage of locally recurrent breast cancer with repeat breast conservation using 45\u00a0Gy hyperfractionated partial breast re-irradiation. Breast Cancer Res Treat. 2021;188(2):409\u201314. https:\/\/doi.org\/10.1007\/s10549-021-06206-7.","journal-title":"Breast Cancer Res Treat."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20147-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:19:27Z","timestamp":1790867967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20147-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20147"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20147-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Brittany Siontis - Consulting Deciphera, Ratio Therapeutics. Tina Hieken - Institutional research funding from Genentech and SkylineDx.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}